December 19, 2022
Boston Cell Standards nabs FDA clearance for IHC test panel to evaluate breast cancers
Continue Reading
December 19, 2022
Boston Cell Standards Wins First-Ever FDA 510(k) Clearance for Anatomic Pathology Controls
Continue Reading
December 19, 2022
Boston Cell Standards Gains 510(k) Clearance for Breast Cancer Test Control Panels
Continue Reading
December 19, 2022
FDA clears Boston Cell Standards’ IHControls panel in breast cancer
Continue Reading
July 11, 2022
Standardization of PD-L1 immunohistochemistry
Continue Reading